Allogeneic stem cell transplantation is considered to be a curative treatment modality in patients with chronic myelogenous leukemia. However patients are at risk for relapse years after transplantation. Currently we present two patients who relapsed 16 and 24 years after allogeneic bone marrow tran
Treatment of hematological malignancies relapsing after allogeneic bone marrow transplantation
β Scribed by J.-M. Boiren; P. Cony-Makhoul; A. Pigneux; M. Puntous; J. Reiffers; J.-M. Boiron; F.-X. Mahon; A. Pigneux; J. Reiffer
- Publisher
- Elsevier Science
- Year
- 1994
- Tongue
- English
- Weight
- 903 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0268-960X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The curative effect of allogeneic bone marrow transplantation (BMT) for acute and chronic leukemia is attributed to the intensive conditioning chemotherapy with or without radiotherapy, as well as an immune-mediated graft versus leukemia (GVL) effect. A different pattern of relapse has been observed
## Abstract We report a patient with a relapsed in bone marrow of extremities after allogeneic peripheral blood stem cell transplantation for acute lymphoblastic leukemia (ALL). The patient complained of pain in the right upper arm and left leg 15 months after transplantation. Magnetic resonance im
## Background: The progressively increasing number of long-term survivors after allogeneic bone marrow transplantation (allo-bmt) led researchers to focus on the early and late complications of this procedure. endocrine dysfunction occurred mostly in patients who had undergone total body irradiatio